Multiple Presentations of LRBA Deficiency: a Single-Center Experience
نویسندگان
چکیده
منابع مشابه
Fetal Echocardiography Indications: A Single- Center Experience
Background Congenital heart disease (CHD) is the most common lethal congenital anomaly. Early diagnosis of CHD by fetal echocardiography based on maternal and fetal indications is important and lifesaving. The aim of study was to assess the referral aspects of pregnant women to pediatric cardiologist. Materials and Methods This was a retrospective cross-sectional study on 250 documents of refer...
متن کاملShort Term Outcome of Antenatal Hydronephrosis: A Single Center Experience
Background Fetal hydronephrosis is a common urinary tract anomaly that may result in renal parenchyma damage. Ultrasound is considered a simple, noninvasive procedure to diagnose and track antenatal hydronephrosis. Our aim was to study the clinical course of fetal hydronephrosis in fetuses. Materials and Methods</...
متن کاملcarotid artery stenting: a single-center experience
background: carotid artery stenting is now used as an alternative to surgical endarterectomy. this study was done to assess the feasibility, safety, and immediate and late clinical outcomes in patients undergoing carotid stenting . methods: between july 2008 and december 2009, a total of 40 patients (20 male, mean age: 65 ± 11 years, 19 symptomatic, and 90% high risk for endarterectomy) underwe...
متن کاملAggressive Fibromatosis, Clinicopathologic Findings of 25 Cases; A Single-Center Experience and Review of the Literature
Background: Aggressive fibromatosis is a rare benign tumor with no potential for metastasis; however, its aggressive nature causes treatment failure and episodes of recurrence. There is no report from Iran about the treatment of this tumor, and all published articles are single-case reports, therefore in this study, we report our experience from two of...
متن کاملEvaluation of immunomodulatory drugs in multiple myeloma: single center experience.
OBJECTIVE Multiple myeloma (MM) comprises 1% of all cancers and 10% of hematologic malignancies and known as an incurable disease. The introduction of immunomodulatory drugs (IMiDs) has brought a major shift in therapeutic paradigm in the treatment of newly diagnosed and relapsed/refractory MM patients. The aim of this study was to evaluate the relationship between response status and hematolog...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Immunology
سال: 2017
ISSN: 0271-9142,1573-2592
DOI: 10.1007/s10875-017-0446-y